ATP11A

Chr 13

ATPase phospholipid transporting 11A

Also known as: ATPIH, ATPIS, AUNA2, DFNA84, HLD24

The protein encoded by this gene is an integral membrane ATPase. The encoded protein is probably phosphorylated in its intermediate state and likely drives the transport of ions such as calcium across membranes. [provided by RefSeq, Apr 2022]

ResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.47
Clinical SummaryATP11A
🧬
Gene-Disease Validity (ClinGen)
autosomal dominant nonsyndromic hearing loss · ADModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.33) despite low pLI — interpret in context.
📋
ClinVar Variants
6 unique Pathogenic / Likely Pathogenic· 205 VUS of 308 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.47LOEUF
pLI 0.000
Z-score 5.19
OE 0.33 (0.240.47)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.37Z-score
OE missense 0.85 (0.800.91)
592 obs / 693.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.33 (0.240.47)
00.351.4
Missense OE?0.85 (0.800.91)
00.61.4
Synonymous OE?1.08
01.21.6
LoF obs/exp: 23 / 69.8Missense obs/exp: 592 / 693.3Syn Z: -1.13

This gene — mechanism propensity

DN
0.74top 25%
GOF
0.78top 25%
LOF
0.2091th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function, gain-of-function and dominant-negative). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF1 literature citation · 33% of P/LP variants are LoF · LOEUF 0.47
GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

LOFHaploinsufficiency of ATP11A, the phospholipid flippase that specially transports phosphatidylserine (PS) and phosphatidylethanolamine (PE), could leave cells with PS/PE at the extracellular side vulnerable to phagocytic degradation.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 35278131

ClinVar Variant Classifications

308 submitted variants in ClinVar

Classification Summary

Pathogenic4
Likely Pathogenic2
VUS205
Likely Benign47
Benign16
Conflicting7
4
Pathogenic
2
Likely Pathogenic
205
VUS
47
Likely Benign
16
Benign
7
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
2
1
0
4
Likely Pathogenic
1
1
0
0
2
VUS
3
200
2
0
205
Likely Benign
1
17
6
23
47
Benign
0
3
2
11
16
Conflicting
7
Total62231134281

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

120 pathogenic / likely-pathogenic (of 136) ClinVar copy-number / structural variants overlap ATP11A — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ATP11A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →